Comments
Target: 1,068
CMP: ₹984.55
Poly Medicure Ltd. (Polymed) is a leading player in the organized medical disposable devices market with strong brand positioning due to high quality products used in infusion therapy, blood management, surgery, dialysis, and other segments. Company is the largest exporter of medical devices from India.
Polymed is among the top three IV Cannula manufacturers in the world and the first indigenous dialyzer manufacturer. Seventy per cent of the sales are from exports to the highly regulated developed markets like EU, LatAm, South East Asia etc.
Key raw materials include plastic granules, PVC sheets, boxes, medical paper and film. So, any large fluctuations in crude and related prices could impact its gross margin. Tailwinds from new capacity additions and additional cost curtailment efforts through automation will drive incremental growth from FY24.
Company is looking at expansion opportunities both organically and inorganically in India and abroad. Polymed’s return ratios got impacted in FY22 on the back of higher cash and equivalents on back of QIP fund raising and flattish earnings growth impacted due to cost inflation.
With improving profitability and asset turnover, we expect return ratios to expand over FY22-25
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.